Table 1.
Role of IFN-α/β in regulating IL-12 production during MCMV infection
Mouse strain | Treatment | Serum IL-12 p40, pg/ml ± SE | Splenic IL-12 p40 production, pg per million cells ± SE |
---|---|---|---|
C57BL/6 | Control Ab | 814 ± 96 | 19.9 ± 3.8 |
Anti-IFN-α/β | 1239 ± 272 | 42.0 ± 4.9 | |
C57BL/6 nude | Control Ab | 271 ± 73 | 1.9 ± 3.0 |
Anti-IFN-α/β | 3041 ± 355 | 21.7 ± 4.4 | |
C57BL/6 SCID | Control Ab | 1055 ± 272 | ND |
Anti-IFN-α/β | 3872 ± 589 | ND |
Mice were treated with control sheep antibody or sheep antibody neutralizing murine IFN-α/β before infection with 2 × 105 plaque-forming units salivary gland extracted MCMV Smith strain. Samples were prepared 2 days after infection. Each point is the mean ± SE of results from 3–4 replicate animals. ND, not done.